However, individualization is key
Tablets could change that, but only if they are introduced responsibly, with the right education, support and expectations in place. Jason Murphy, Head of Pharmacy at Chemist4U The needle barrier holding people back GLP-1 injections have revolutionised weight loss, allowing those facing obesity and other weight-related conditions to take a meaningful step towards a healthier life
while normal dietary intake is considered safe, the effects of high-dose parenteral administration are less well studied
For example, the tripeptide RGD, a common cell-targeting peptide, can serve as a targeting moiety for the anticancer drug cyclophosphamide (CP), offering high loading capacity and the potential for slow, prolonged drug release